ロード中...

Partial Response to Platinum Doublets in Refractory EGFR-Positive Non-Small Cell Lung Cancer Patients after RRx-001: Evidence of Episensitization

RRx-001, an experimental systemically non-toxic epi-immunotherapeutic agent, which potentiates the resensitization of resistant cancer cells to formerly effective therapies, is under active investigation in several clinical trials that are based on sequential or concomitant rechallenge to resistant...

詳細記述

保存先:
書誌詳細
出版年:Case Rep Oncol
主要な著者: Carter, Corey A., Oronsky, Bryan T., Caroen, Scott Z., Scicinski, Jan J., Cabrales, Pedro, Reid, Tony, Degesys, Aiste, Jenkins, John, Brzezniak, Christina
フォーマット: Artigo
言語:Inglês
出版事項: S. Karger AG 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4772628/
https://ncbi.nlm.nih.gov/pubmed/26933421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000443725
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!